Recall of McKinley T34 extension sets
28th April 2011
The MHRA have issued a recall of all T34 syringe pump extension sets manufactured by CME (McKinley Medical UK). before 1 January 2011. This is due to the potential for leakage at the female luer syringe connector.
The product codes affected are: 100-172S, 100-170S, 100-172SLL, 100-172SB, 100-172SC.
Returns and replacement stock can be obtained by contacting Paul Fletcher (McKinley Medical UK, 01253 894646, email: pfletcher@cme-mckinley.co.uk). The manufacturer states that other syringe sets can be used in the interim (ensuring local guidelines and practice are adhered to),
FDA announces REMS for m/r opioids
27th April 2011
The US Food and Drug Administration (FDA) has published its Risk Evaluation and Mitigation Strategy (REMS) for all modified-release opioid drugs which focuses on reducing the misprescribing, misuse, and abuse of opioids. The REMS requires manufacturers to develop an educational program for prescribers and patients. For more information see the FDA Question and Answer document below.
Recent news
- Die zweite Ausgabe des APM Newsletter ist fertig.
- Prescribing and mixing controlled drugs - changes
- Tolvaptan: over-rapid increase in serum sodium and risk of serious neurological events
- Risks of hypomagnesaemia and increased risk of fracture with long-term PPI use
- NICE updated infection control guidelines
- MHRA alert for co-codamol 8/500 tablets
- NPSA RRR: Harm from flushing of nasogastric tubes before confirmation of placement
- Capsaicin patch license extension application withdrawn
- Wir freuen uns, Ihnen den ersten APM Newsletter vorstellen zu dürfen
- Alert update on Prednisolone e/c recalled from Teva
News archive
- 2012
- 2011
- 2010
- 2009
- 2008
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000